Abstract:Background: Medical tourism (MT) is an increasingly utilized modality for acquiring medical treatment for patients globally. This review assimilates the current literature regarding MT, with particular focus on the applications, ethics and economics. Methods: A systematic review of MEDLINE and PubMed Central databases for publications relating to MT from 2005 to 2018 yielded 43 articles for this review. Results: Patients seeking elective bariatric, cosmetic and orthopedic surgery abroad are motivated by significantly lower costs, all-inclusive vacation packages and reduced wait times. Complication rates as high as 56% include infection, poor aesthetic and functional outcome and adverse cardiovascular events. Cross-border reproductive care has steadily increased due to less restrictive policies in select countries; however, the depth of research on outcomes and quality of care is abysmal. Stem cell therapy promise treatments that are often not well researched and offer minimal evidence of efficacy, yet patients are drawn to treatment through anecdotal advertisements and a last sense of hope. Transplant surgery sought to decrease wait times carries many of the similar aforementioned risks and may contribute to the practice of organ trafficking in countries with high rates of poverty. Patients and countries alike are motivated by a plethora of factors to engage in the MT industry but may be doing so without accurate knowledge of the quality, safety or potential for economic gain. Safety is of utmost importance to prevent surgical complications and the spread of treatment-resistant bacteria. Conclusions: MT is growing in popularity and complexity. The lack of standardization in its definition and regulation leads to difficulty in epidemiologic and economic analysis and ethical issues of informed consent and health equity. The findings of this review may be used by the stakeholders of MT, including patients and providers, to enhance informed decision-making and quality of care.

Stem Cell Tourism and International Trade of Unapproved Stem Cell Interventions

What's missing? Discussing stem cell translational research in educational information on stem cell "tourism"

Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers

Patient care without borders: a systematic review of medical and surgical tourism

Patients Beware: Commercialized Stem Cell Treatments on the Web.

Stem Cell Therapy: From Idea to Clinical Practice

Transplant tourism or international transplant medicine? A case for making the distinction

Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics

Stem Cell Based Products in Europe and in China: Where Are We and Where Should We Go?

Effective regulatory responses to predatory stem cell markets in Australia and Canada

Application of Stem Cell Therapy for Infertility

Medical tourism today: What is the state of existing knowledge?

Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine

How do I: Evaluate the safety and legitimacy of unproven cellular therapies?

The global landscape of stem cell clinical trials

Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Transplant tourism following the declaration of Istanbul: Poor outcomes and nephrologist dilemma

Considerations of Quality Control Issues for the Mesenchymal Stem Cells-Based Medicinal Products

Designing persuasive health education for patients seeking unproven stem cell interventions

Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception